Elicio Therapeutics Inc.
ELTX
$1.87-2.58%
Delayed · as of Oct 6, 2026, 3:45 PM ET
Mkt cap
$132.30M
EV/Sales
53.5
P/E ratio
N/A
FY2022 Revenue
$2.30M
EPS (H1 2026)
$-1.07
Gross Margin (FY2022)
N/A
Profit Margin (FY2022)
-1686.53%
Beta
2.16
Div yield
N/A
Sector
Healthcare
Elicio Therapeutics Inc. (ELTX) is a biotechnology company listed on US.
Latest reported ELTX revenue for 2022-12-31 was $2.3M. Net income was -$38.8M. ELTX currently screens at market cap $132.3M.
Use this ELTX research hub for sector, financials, and filings — not a live tape.
Latest cached year on this hub. Full ELTX income, balance, and cash tables.
† Total Debt: Derived from long-term debt only (no total or short-term debt stored).
Elicio Therapeutics Inc. (ELTX) is a biotechnology company in the Healthcare sector.
Latest cached Elicio Therapeutics Inc. (ELTX) revenue for Dec 31, 2022 was $2.3M. Net income was -$38.8M. Statements: https://lician.com/financials/eltx
Elicio Therapeutics Inc. (ELTX) market capitalization is $132.3M on the latest cached snapshot.
Elicio Therapeutics Inc. (ELTX) cached previous close $1.92; day range $1.87 – $1.96; volume 223,780. Session quote: https://lician.com/quote/eltx
Elicio Therapeutics Inc. (ELTX) latest cached earnings event is "ELTX earnings" on Aug 13, 2026. Earnings calendar: https://lician.com/earnings
The latest cached ELTX filing is 8-K · Sep 14, 2026. Filings: https://lician.com/sec/eltx